drugset / Trial / NCT03565159

Pneumococcal Vaccination to Accelerate Immune Recovery in Sepsis Survivors

NCT03565159

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The VACIRiSS trial is a phase-IV, multi-centre placebo controlled randomised trial of conjugate pneumococcal vaccine in adult sepsis survivors.

Timeline

Start
2018-08-02
Primary completion
2023-08-31
Completion
2023-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prevnar 13 Vaccine 0.5 ml